                </a></li></ul></div><p><strong>Figure 1.  <span>Structural model of human TPI. (Upper panel) </span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>The pathogenic TPI variants Cys41Tyr, Glu104Asp, Gly122Arg, Ile170Val and Phe240Leu were assigned to the crystal structure of human TPI generated by Kinoshita et al <a href="#pone.0000030-Kinoshita1">[38]</a>; NT: amino terminus. </p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p2" name="article1.body1.sec3.sec1.fig1.caption1.p2"></a><p>
                     <strong>(Lower panel)</strong> Appearance of pathogenic TPI variants among TPI deficiency patients (c.h.: compound heterozygous; n.d.: not determined).</p>
